Cellular adhesion regulates p53 protein levels in primary human keratinocytes

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3635-3639

  Nigro, Janice M ^a   Aldape, Kenneth D ^a   Hess, Suzanne M ^b   Tlsty, Thea D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CELL ADHESION; CELL POPULATION; CELL PROLIFERATION; DNA DAMAGE; EPITHELIUM CELL; FIBROBLAST; GENE REARRANGEMENT; GENETIC STABILITY; HUMAN; HUMAN CELL; KERATINOCYTE; PREPUCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

CELL ADHESION; CELL CYCLE; CELL NUCLEUS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; FIBROBLASTS; HUMANS; KERATINOCYTES; MALE; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030880746     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Tlsty, T. D., White, A., Livanos, E., Sage, M., Roelofs, H., Briot, A., and Poulose, B. Genomic integrity and the genetics of cancer. Cold Spring Harbor Symp. Quant. Biol., 59: 265-275, 1994.
2. MacCallum, D. E., Hupp, T. R., Midgley, C. A., Stuart, D., Campbell, S. J., Harper, A., Walsh, F. S., Wright, E. G., Balmain, A., Lane, D. P., and Hall, P. A. The p53 response to ionising radiation in adult and developing murine tissues. Oncogene, 13: 2575-2587, 1996.
3. Lutzker, S. G., and Levine, A. J. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat. Med., 2: 804-810, 1996.
4. Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., van Heyningen, V., and Hastic, N. The candidate Wilms' tumour gene is involved in genitourinary development. Nature (Lond.), 346: 194-197, 1990.
5. Maheswaran, S., Englert, C, Bennett, P., Heinrich, G., and Haber, D. A. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev., 9: 2143-2156, 1995.
6. Delmolino, L., Band, H., and Band, V. Expression and stability of p53 protein in normal human mammary epithelial cells. Carcinogenesis (Lond.), 14: 827-832, 1993.
7. Blanton, R. A., Coltrera, M. D., Gown, A. M., Halbert, C. L., and McDougall, J. K. , Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth Differ., 3: 791-802, 1992.
8. Hubbert, N. L., Sedman, S. A., and Schiller, J. T. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J. Virol., 66: 6237-6241, 1992.
9. Weinberg, W. C., Azzoli, C. G., Chapman, K., Levine, A. J., and Yuspa, S. H. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. Oncogene, 10: 2271-2279, 1995.
10. Xiong, Y., Kuppuswamy, D., Li, Y., Livanos, E. M., Hixon, M., White, A., Beach, D., and Tlsty, T. D. Alteration of cell cycle kinase complexes in human papillomavirus E6-and E7-expressing fibroblasts precedes neoplastic transformation. J. Virol., 70: 999-1008, 1996.
11. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
12. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
13. Moll, U. M., LaQuaglia, M., Benard, J., and Riou, G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA, 92: 4407-4411, 1995.
14. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69: 1237-1245, 1992.
15. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (Lond.), 358: 80-83, 1992.
16. Juliano, R. Cooperation between soluble factors and integrin-mediated cell anchorage in the control of cell growth and differentiation. BioEssays, 18: 911-917, 1996.
17. Adams, J. C., and Watt, F. M. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature (Lond.), 340: 307-309, 1989.
18. Kikuchi, K., Tsutsumi, K., Ohta, Y., and Yasumoto, S. Time correlation of commitment to calcium-induced apoptosis and terminal differentiation in human ectocervical keratinocytes in suspension cultures. Cell Growth Differ., 8: 571-579, 1997.
19. Zhu, X., and Assoian, R. K. Integrin-dependent activation of MAP kinase: a link to shape-dependent cell proliferation. Mol. Biol. Cell, 6: 273-282, 1995.
20. Su, L. K., Vogelstein, B., and Kinzler, K. W. Association of the APC tumor suppressor protein with catenins. Science (Washington DC), 262: 1734-1737, 1993.
21. Rubinfeld, B., Souza, B., Albert, I., Muller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., and Polakis, P. Association of the APC gene product with β-catenin. Science (Washington DC), 262: 1731-1734, 1993.
22. Hodivala, K. J., and Watt, F. M. Evidence that cadherins play a role in the down-regulation of integrin expression that occurs during keratinocyte terminal differentiation. J. Cell. Biol., 124: 589-600, 1994.
23. Neshat, K., Sanchez, C. A., Galipeau, P. C., Blount, P. L., Levine, D. S., Joslyn, G., and Reid, B. J. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology, 106: 1589-1595, 1994.
24. Magee, J. W., McCalmont, T. H., and LeBoit, P. E. Overexpression of p53 tumor suppressor protein in porokeratosis. Arch. Dermatol., 130: 187-190, 1994.
25. Kemp, C. J., Donehower, L. A., Bradley, A., and Balmain, A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell, 74: 813-822, 1993.
26. Greenhalgh, D. A., Wang, X. J., Donehower, L. A., and Roop, D. R. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor α. Cancer Res., 56: 4413-4423, 1996.